Vanguard ESG Developed Europe Index Fund GBP DistRegister to Unlock Ratings |
Performance History | 30/06/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.8 | 18.0 | -5.5 | 13.7 | 7.0 | |
+/-Cat | -0.5 | 2.6 | 2.8 | 2.1 | 1.3 | |
+/-B’mrk | 1.2 | 0.3 | -1.0 | 0.5 | 0.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 15/07/2024 | GBP 198.63 | |
Day Change | -0.79% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
IA (formerly IMA) Sector | Europe Including UK | |
ISIN | IE00B76VTR58 | |
Fund Size (Mil) 15/07/2024 | EUR 593.36 | |
Share Class Size (Mil) 15/07/2024 | GBP 13.60 | |
Max Initial Charge | - | |
Ongoing Charge 24/06/2024 | 0.14% |
Investment Objective: Vanguard ESG Developed Europe Index Fund GBP Dist |
The Fund aims to provide long-term growth of capital by seeking to achieve the performance of the FTSE Developed Europe Choice Index. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 29/06/2010 | ||
Inception Date 25/10/2011 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE Developed Eur Choice NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Vanguard ESG Developed Europe Index Fund GBP Dist | 31/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.68 |
ASML Holding NV | Technology | 3.26 |
Nestle SA | Consumer Defensive | 2.52 |
Shell PLC | Energy | 2.14 |
AstraZeneca PLC | Healthcare | 2.04 |
Increase Decrease New since last portfolio | ||
Vanguard ESG Developed Europe Index Fund GBP Dist |